Difference between revisions of "Hodi FS, et al. N. Engl. J. Med. (2010) cited as Ref 642 in DOI: 10.1038/s41392-020-0110-5 (Q9905)"
Jump to navigation
Jump to search
(Created claim: title (P93): Improved survival with ipilimumab in patients with metastatic melanoma, #quickstatements; #temporary_batch_1590010982689) |
(Created claim: Page(s) (P105): 711-723, #quickstatements; #temporary_batch_1590074839150) |
||
| Property / Page(s) | |||
| + | 711-723 | ||
| Property / Page(s): 711-723 / rank | |||
| + | Normal rank | ||
Latest revision as of 15:47, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Hodi FS, et al. N. Engl. J. Med. (2010) cited as Ref 642 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Hodi FS
0 references
2010
0 references
N. Engl. J. Med.
0 references
363
0 references
Improved survival with ipilimumab in patients with metastatic melanoma (English)
0 references
711-723
0 references
